Clinical Trials Directory

Trials / Completed

CompletedNCT01764555

Pharmacokinetics of Acetaminophen in Morbidly Obese Patients

Pharmacokinetics of Intravenous Acetaminophen and Its Metabolites in Morbidly Obese Patients

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
28 (actual)
Sponsor
St. Antonius Hospital · Academic / Other
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Accepted

Summary

This study will investigate the pharmacokinetics of acetaminophen in morbidly obese patients versus normal weight patients. Specifically the different metabolic pathways of acetaminophen in morbidly obese adults will be investigated; glucuronidation, sulphation and CYP2E1 (cytochrome P450 2E1) oxidation

Conditions

Interventions

TypeNameDescription
DRUGacetaminophen 2 g

Timeline

Start date
2012-12-01
Primary completion
2014-03-01
Completion
2014-03-01
First posted
2013-01-09
Last updated
2019-04-05

Locations

1 site across 1 country: Netherlands

Source: ClinicalTrials.gov record NCT01764555. Inclusion in this directory is not an endorsement.

Pharmacokinetics of Acetaminophen in Morbidly Obese Patients (NCT01764555) · Clinical Trials Directory